Skip to main content
NewslettersWatchlist

Blueprint Medicines Corp(BPMC-Q)
NASDAQ

Today's Change
Delayed Last Update

Blueprint Medicines Corp

45 SIDNEY STREET
CAMBRIDGE MA 02139 USA
P: 617-374-7580
http://www.blueprintmedicines.com

Sectors & Indices

Sector
Industry
Employees

    Profile

    Blueprint Medicines Corporation is a biopharmaceutical company focused on developing the potentially transformational precision medicines to address patients with genomically defined cancers and rare diseases.

    Key Executives

    NameTitle
    Information not available.

    More from The Globe

    Bullish on Northrop Grumman Corp.
    Monica Rizk
    opinion
    Which P/E ratio measures markets better: trailing or forward? The answer is sure to spook investors right now
    George Athanassakos
    The stock picks of CIBC’s Mokhtari continue to blow past the TSX Composite. Here are his latest favourites
    Sid Mokhtari, chief market technician at CIBC Capital Markets.
    The most oversold and overbought stocks on the TSX
    The TMX Market Centre is shown in Toronto, Wednesday, Sept. 11, 2024.
    top links
    CIBC analyst details office REIT rally, reiterates top picks in broader sector
    Scott Barlow
    Trump has his eye on Canadian forestry stocks. You should, too
    David Berman
    top links
    Six Canadian stocks among RBC’s top 30 global ideas
    Scott Barlow
    Analysts’ forecast returns, recommendations and yields for all stocks in the S&P 500
    Traders work on the floor of the New York Stock Exchange (NYSE) on Oct. 1.

    All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2025.

    Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

    Financial data provided by Zacks Investment Research.